ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

475
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Refresh
bullishCelltrion Inc
18 Sep 2018 22:54

Celltrion Healthcare Placement: Two Mitigating Factors, Short Healthcare But Long Celltrion

It is quite clear that Celltrion Healthcare (091990 KS) didn't do well in the previous placement (by Temasek) back on Mar 6. The price...

Logo
780 Views
Share
18 Sep 2018 17:37

Celltrion Healthcare Placement: Weigh Down from FDA Uncertainty and Placement Overhang

Celltrion Healthcare's shareholder, One Equity Partners, is selling USD 355 million of shares via a secondary placement today. This is the first...

Logo
471 Views
Share
30 Aug 2018 10:29

Another Negative Sign for Celltrion: Remsima Retail Price Is Falling Too Fast Too Much

Celltrion Healthcare (091990 KS) submitted its 1H18 semi-annual report yesterday. And with this semi-annual report, we finally got to know the...

Logo
767 Views
Share
bearishCelltrion Inc
14 Aug 2018 07:09

Celltrion (068270): Time Is Not Right for Short Sellers Yet

First, let me tell you this. I'm also a Celltrion basher. I don't like their accounting practices and dual company structure. Not only that,...

Logo
369 Views
Share
bearishCelltrion Inc
08 Aug 2018 03:59

Celltrion: Manufacturing Risks Remain

Celltrion Inc (068270 KS) continues to struggle with meeting the USFDA's standards for Good Manufacturing Practices. The agency issued a Form 483...

Share
x